Drug
Vilazodone clinical trials
Also written Viibryd.
- studies test it
- 26
- open now
- 0
- in phase 3
- 9
- first study started
- 2006
How studies write it
Studies that test it under each name
Other names
- Viibryd
- 15
Studies by the year they started
25 studies that test it; most in 2012 (9)
| Year | Studies |
|---|---|
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2011 | 2 |
| 2012 | 9 |
| 2013 | 6 |
| 2014 | 1 |
| 2015 | 2 |
| 2021 | 1 |
| 2025 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 1
- Phase 2
- 5
- Phase 3
- 9
- Phase 4
- 8
- No phase
- 3
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 13 · Other 13
Forest Laboratories (11) · Nexira (1) · University of Chicago (1) · University of Texas Southwestern Medical Center (1) · University of California, Los Angeles (1) · New York State Psychiatric Institute (1) · Southern California Institute for Research and Education (1) · Medical University of South Carolina (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses vilazodone is read from its arms, and is right about nine times in ten.
Testing it · 26
- Acute Effect of Polyphenols Supplementation on Endothelial Function and Exercise Related Markers, in Physically Active Healthy Volunteers.Active, not recruitingNot applicableNexiraNCT07518758Written as Oral administration
- Εffectiveness of Intrauterine Antibiotic Administration for Treatment of Chronic EndometritisStatus unknownPhase 2Genesis Athens ClinicNCT05205993Written as Oral administration
- Double-Blind Treatment of Major Depressive Disorder With VilazodoneCompletedPhase 2University of ChicagoNCT01742832Written as Vilazodone
- Safety and Efficacy of Vilazodone in Adolescent Patients With Major Depressive DisorderCompletedPhase 3Forest LaboratoriesNCT01878292Written as Vilazodone
- Safety, Efficacy and Tolerability of Vilazodone in Generalized Anxiety DisorderCompletedPhase 3Forest LaboratoriesNCT01629966Written as Vilazodone
- Safety, Efficacy and Tolerability of Vilazodone in (GAD) Generalized Anxiety DisorderCompletedPhase 3Forest LaboratoriesNCT01844115Written as Vilazodone
- Safety and Efficacy of Vilazodone in Pediatric Patients With Major Depressive Disorder (VLZ-MD-22)CompletedPhase 3Forest LaboratoriesNCT02372799Written as Vilazodone
- A Study of Vilazodone in Pediatric Patients With Major Depressive DisorderCompletedPhase 3Forest LaboratoriesNCT02436239Written as Vilazodone
- Vilazodone for Corticosteroid-Induced Memory ImpairmentCompletedPhase 2University of Texas Southwestern Medical CenterNCT01828515Written as Vilazodone
- Vilazodone for Treatment of Geriatric DepressionCompletedPhase 4University of California, Los AngelesNCT01608295Written as Vilazodone; Viibryd
- Vilazodone for Separation Anxiety DisorderCompletedPhase 4New York State Psychiatric InstituteNCT01999920Written as Vilazodone
- A One Year Open Label Study Assessing the Safety and Tolerability of Vilazodone in Patients With Major Depressive Disorder (MDD)CompletedPhase 3Forest LaboratoriesNCT00644358Written as vilazodone
- Vilazodone for the Treatment of Posttraumatic Stress DisorderCompletedPhase 4Southern California Institute for Research and EducationNCT01715519Written as Treatment (Viibryd)
- The Effects of Vilazodone on Glutamate in the Anterior Cingulate Cortex in Anxious Unipolar DepressivesWithdrawnPhase 4Massachusetts General HospitalNCT02028026Written as Vilazodone
- Does Vilazodone Help With Antidepressant-associated Sexual Dysfunction?TerminatedPhase 4Thomas Jefferson UniversityNCT01856127Written as Vilazodone
- Vilazodone Treatment for Marijuana DependenceCompletedPhase 2Medical University of South CarolinaNCT01574183Written as Vilazodone
- Safety and Efficacy of Vilazodone in Major Depressive DisorderCompletedPhase 4Forest LaboratoriesNCT01573598Written as Vilazodone
- Switching From Generic Selective Serotonin Reuptake Inhibitors (SSRIs) and Selective Serotonin and Norepinephrine Reuptake Inhibitors (SNRIs) to Three Different Dose Initiation Strategies With VilazodoneCompletedPhase 3Duke UniversityNCT02015546Written as Vilazodone
- Study to Evaluate the Sexual Functioning of Healthy Adults After Receiving Vilazodone, Paroxetine or PlaceboCompletedPhase 1Forest LaboratoriesNCT02097147Written as Vilazodone 20 mg
- Vilazodone for Menopausal Hot FlashesCompletedNot applicableUniversity of PennsylvaniaNCT01680900Written as vilazodone
Codes
What other systems call vilazodone · ClinicalTrials.gg INT006605
- MeSH (NLM) D000069503Vilazodone HydrochlorideConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) S239O2OOV3VILAZODONEConfirmed FDA, NLM, Wikidata
- RxNorm 1086769Confirmed FDA, Wikidata
- Wikidata Q408588vilazodoneConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C90716VilazodoneOne source FDA
- DrugBank DB06684One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D000069503 | Vilazodone Hydrochloride | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | S239O2OOV3 | VILAZODONE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 1086769 | — | Confirmed FDA, Wikidata |
| Wikidata | Q408588 | vilazodone | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C90716 | Vilazodone | One source FDA |
| DrugBank | DB06684 | — | One source Wikidata |
Also registered as vilazodone hydrochloride (UNII U8HTX2GK8J · RxNorm 1086768).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.